RCMNY
IRWD icon

Rubric Capital Management (New York)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Rubric Capital Management (New York)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,014,900
Closed -$14.5M – 56
2017
Q1 		$14.5M Sell
1,014,900
-507,450
-33% -$6.94M 4.22% 9
2016
Q4 		$19.5M Buy
+1,522,350
New +$19.2M 6.7% 3

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Rubric Capital Management (New York)'s IRWD Position: Q2 2017 in Review

Rubric Capital Management (New York) sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2017, closing a stake of 1,014,900 shares — an estimated $14.5M sold.

Rubric Capital Management (New York) first reported a position in IRWD in Q4 2016 and held it in 2 quarters. The position peaked at $19.5M in Q4 2016. 167 funds tracked by Wall St. Rank hold IRWD as of Q2 2017.

  • Rubric Capital Management (New York) reported no remaining Ironwood Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 1,014,900 Ironwood Pharmaceuticals shares in Q2 2017, an estimated $14.5M.
  • Rubric Capital Management (New York) first reported a position in Ironwood Pharmaceuticals in Q4 2016 and held it in 2 quarters.
  • Rubric Capital Management (New York)'s Ironwood Pharmaceuticals position peaked at $19.5M in Q4 2016.
  • 167 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2017.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2017, filed 2 Aug 2017.